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Recent evidence supports the idea that matrix metalloproteinases (MMPs) act as morphogenetic regulators in embryonic 
and adult events of tissue remodeling. MMP activity is controlled primarily at the level of gene expression. In a recent study 
we characterized the transcriptional promoter of the M/VIP gene, gelatinase B (gelB), in transgenic mice, demonstrating the 
requirement for DNA sequences between -522 and +19 for appropriate activity. In this study we investigated factors 
required for gelB promoter activity in the developing eye and reepithelializing adult cornea. Pax-6 is a homeobox and paired 
domain transcription factor that acts at the top of the hierarchy of genes controlling eye development. Pax-6 is also 
expressed in the adult eye. We show here that the tissue expression pattern of Pax-6 overlaps extensively with gelB promoter 
activity in the developing and adult eye. In addition Pax-6 is observed to be upregnlated in repairing corneal epithelium, as 
is gelB promoter activity. In cell culture transfection experiments, we identified two promoter regions which mediate 
positive response to Pax-6. By electrophoretic mobility shift assay, we further pinpoint two Pax-6 binding sites within these 
response regions and denmnstrate direct interaction of the Pax-6 paired domain with one of these sites. These data suggest 
a mechanism by which Pax-6 may direct gelB expression in an eye-specific manner. © 2000 Academic Press 
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INTRODUCTION 
The Pax proteins are a family of developmental regulators 
characterized by the paired domain (PD; ~ gopp et a]., 1986; 
Treisman et aI., 1991), an evolutionarily conserved DNA- 
binding motif, first identified in the prototype Drosophila 
gene paired (prd; Frigerio et al., 1986). One of these family 
members, Pax-6, resides at the highest level of a genetic 
hierarchy controlling eye development in species as diverse 
as flies and humans (Glaser et al., 1994,1995; Halder et al., 
1995a,b; Fini et al., 1997). Mutations in Pax-6 are the basis 
~Abbreviations used: /3~gal, /3-galactosidase~ CAT, chloram~ 
phenicol acetyl transferase; ECM, extracellular matrix; EMSA, 
electrophoretic mobility shift assay; gelB, gelatinase B; MMPs, 
matrix metalloproteinases; PD, paired domain; TPA, phorbol ac- 
etate; TRE, TPA response element, 
of mouse and rat small eye and Drosophila eydess. Ho- 
mozygosity for these loss-of-function nmtations is lethM, 
and the phenotype includes brain defects, lack of nasal 
cavities, and complete lack of eyes (Sander et al., 1997). 
Heterozygosity (haploinsufficiency) is associated with a 
spectrum of eye defects in animals and in humans, most 
involving structures in the anterior segment including the 
iris and cornea (Ton et aL, 1991; Glaser et aL, 1992; Hansen 
eta]., 1994). Strikingly, increased Pax-6 gene dosage (deliw 
ered in transgenic mice) causes developmental bnormali- 
ties of the eye sirnilar to those associated with haploinsuf- 
ficiency (Schedl et al., 1996). These observations suggest 
that cells within the eye are exceptionally sensitive to 
changes in levels of Pax-6 activity. Pax-6 protein has also 
been shown to be present in the adult eye (Koroma et aL, 
1997). Thus constitutive Pax-6 may be involved in the 
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maintenance and remodeling of adult tissues; however, few 
data have been presented so far concerning its function in 
this regard. 
Matrix metalloproteinases (MMPs) are a family of zinc 
endopeptidases characterized by reactivity toward compo- 
nents of the extracellular matrix. MMPs were first identi- 
fied in tissues undergoing norm.al developmental or adult 
remodeling and in tissues undergoing pathological destruc- 
tion. Primarily because of MMP suhstrate specificity, it was 
traditionally held that their morphogenetic role was as 
effector: to mediate normal ECM dismantling when prop- 
erly regulated or to destroy ECM structures when disregu- 
lated (Gross, 198 l J. Evidence has been accumulating, how- 
ever, to support the idea that MMPs act as true 
morphogenetic regulators. Thus, it has been increasingly 
appreciated that interaction with ECM can control cell 
behavior and differentiation and that this interaction can be 
exquisitely modulated by MMPs (Boudreau and BisseI, 
1998). Moreover, MMP substrate specificity is now known 
to be much broader than originally thought and includes 
such morphogenetic regulators as cytokines and cell adhe- 
sion molecules (Wilson and Matrisian, 1996; Vu and Werh, 
1998; Werb and Chin, 1998), In view of these advances, it is 
not surprising that recent studies examining perturbation of 
MMP activity have revealed dramatic effects on tissue 
patterning, in both embryo and adult (Chin and Werb, 1997; 
Rudolph-Owen et al., 1998; Thomasset et aL, 1998; Vu et 
al., 1998). 
MMP activity is modulated at multiple levels; however, 
gene expression is the key regulatory eve:nt (Fini et al., 
1998). Thus, MMPs are expressed according to a precise 
temporospatiaI pattern in the embryo and adult that is 
thought to reflect functional requirements. MMP expres- 
sion can also be induced in most tissues by inflammatory, 
stress, or repair stimuli, A large body of work over the past 
10 years has defined factors controlling MMP gene expres- 
sion in response to stress-related stimuli (Fini et al., 1998). 
Expression of several of the MMP genes, including collage- 
nase (MMP-I), stromelysin (MMP-3), and gelatinase B (gelB; 
MMP-9) can be stimulated by tumor-promoting phorbol 
esters such as TPA or by growth factors and inflammatory 
cytokines. In transient ransfection assays, basal or stimu- 
lated activity of the transcriptional promoter typically 
requires a TPA-response lement (TRE), which binds tran- 
scription factor Ab l .  Additional elements which modulate 
transcription have been identified. For example; in the gelB 
gene, there are two TREs present in the first 600 hp 
upstream of the transcriptional start site, and ;it least one of 
these must be intact for promoter activity (Sato and Seiki, 
1993; Fini et al., 1994). Deletion of other DNA sequences, 
including but not restricted to response sites for transcrip- 
tion factors NF-KB, Spl, and AP-2, affect the activity of the 
gelB gene, but are not ahsolutely essential for promoter 
activity in transient transfection assay (Sato and Seiki, 
1993; Sato et  al., 1993; Fini et  al., 1994; Gum et  al., 19961. 
In contrast o the large amount of work on stress regula- 
tors, very few studies have considered mechanisms ofMMP 
regulation during development. We recently began to inves- 
tigate this territory by undertaking the first analysis of a 
MMP gene transcriptional promoter i~ v ivo:  the promoter 
for the rabbit gene for gelB. We found that DNA sequences 
between -522 and +19 of the rabbit gelB promoter, as 
exemplified in our transgenic mouse line 3445) are suffi- 
cient for developmental, dult, and repair-specific reporter 
gene activity according to a pattern which closely parallels 
expression of the endogenous gelB gene (Mohan et al., 
1998). In contrast o requirements in transient transfection 
assay, truncation or internal deletion of promoter se- 
quences between -522 and +19, even when both TREs 
were left intact, eliminated promoter function in vivo. 
These studies emphasize the importance of elements other 
than the TRE in expression of the gelB gene for both 
developmental and stress-related promoter activity in vivo. 
Pax-6 has a highly localized expression pattern during 
development in distinct regions of the forebrain and hind- 
brain, the spinal cord, the pituitary, the pancreas, the nasal 
epithelium, and the developing and adult eye (Koroma et 
a]., 1997; Sander et al., 1997). In s i tu hybridization and 
immunolocalization studies have revealed that like Pax-6, 
gelB is also expressed evelopmentally in the brain, spinal 
cord, and eye (Reponen et al., 1994; Canete-Soler et al., 
1995a, b) and is induced in many adult tissues during 
healing or regenerative processes (Fini et oL, 1998). During 
studies to characterize gelB promoter activity in our trans- 
genic mouse line 3445, we were struck by the similarities 
between promoter activity and Pax-6 gene expression pat- 
terns (Mohan et al., 1998). In particular, the whole-mount 
staining technique for assay of gelB promoter activity 
prominently highlighted the eye at embryonic day 13. 
Strong promoter activity also occurred at this time in the 
nasal cavities, a gelB expression site which had not been 
previously reported. Together with the localized expression 
in specific areas of the brain and spinal cord, a picture 
emerged of striking overlap with the developmental expres- 
sion pattern for Pax-6 and hinted that gelB might be a 
downstream target for Pax-6. 
In this study, we investigate the hypothesis that Pax-6 
regulates activity of the getB promoter and further charac- 
terize the expression and activity of Pax-6 in the reepithe- 
lializing cornea. 
MATERIALS AND METHODS 
Assay of Transgene Expression in Mouse Line 3445 
Construction of mouse line 3445, which harhors the Pr22 
transgene, was previously described (Mohan et al, 1998). The 
transgene consists of bases -522 to +19 of the gelB promoter 
linked to a jd~gal reporter. Promoter activity in these mice closely 
parallels the activity of the endogenous gelB gene (Mohan et al., 
1998). Embryos from matings between line 3445 mice heterozy- 
gous for the transgene and from wild-type CDq mice were col- 
lected at staged intervals, fixed in buffered 4% paraformaldehyde 
for 25 rain, washed three times in PBS, and stained as whole 
mounts in buffered 2% X-gal solution at 30°C for 5 to 12 h 
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TABLE l 
Oligonucleotide Probes Used for EMSA 
GelB promoter p obes 
RM82/83, bases 570  to o~524 
CACTGCCCTGAAGATTCAGCTGTCGGAGACAGGGGTTACCCCGGTG 
RM80/81, bases -~5t5 to -~---467 
CAAATCCTGCCTCAGAGAGCCCACTCCTTGGG.QCCAGCTGGAGCCGGGA 
BF10/11, bases -.408 to ---388 
CCTC AGGAGGGGGTGTCACAG 
RM72/73, bases -385 to -359 
TCAAGGGTGGGCCTGGGGTGGCACTCA 
BFS/9, bases -233 to -206 
GGCCTGTGGTTTCCTGTGGGTCTGGGGT 
Control probes 
PDcon (optimized Pax-6 paired domain binding site) 
TGGAATTCAGGAAAAATTTTCACGCTTGAGTTCACAGCTCGTC GAGTA 
AP-2con (canonical AP2 binding site) 
GATCGAACTGACCGCCCGCGGCCCGT 
APlcon (canonical AP1 binding site) 
CGCTTGATGAGTCAGCCGGAA 
SPlcon (canonical SP1 binding site) 
ATTCGATCGGGGCGGGGCCAGC 
NFKBcon (canonical NFKB binding site) 
AGTTGAGGGGACTTTCCCAGGC 
Note. Underlined in RM80/8l is an Spl binding site conserved between human and rabbit. The second underline is a second site which 
fits the Spl binding consensus. Underlined in RM72/73 is a region which is protected by footprinting with AP-2 (Eini et aI., 1994). This 
element also binds Spl (Mohan and Fini, unpublished data) 
(Wasserman et al., 1993). Genetics predicts that half of these 
embryos will not carry the transgene and therefore will serve as a 
control for nonspecific staining. Adult eyes were surgically re- 
moved from the mice and fixed and stained as above. After staining, 
the tissues were washed in PBS and refixed in 4% paraformalde- 
hyde, then embedded in paraffin and sectioned (6/xm). 
Immunohistochemistry 
Wild-type embryonic day 13 (El3) mice and adult mouse eyes 
were frozen i  liquid nitrogen and sectioned at 5 and 7/zm on a 
cryostat, respectively. Sections were fixed in 4% paraformaldehyde 
for 10 rain t4°C) followed by permeabilization in 0.5% NP-40/PBS 
for 5 min and blocking in 3% goat serum for 1 h at room temp. 
Incubation with potyclonal Pax-6 antibody (purchased from Co- 
vance Co., Richmond CA) was performed in 1.5% goat serum for 
1.5 h at a dilution of 1:200 in PBS. Then FITC-conjugated secondary 
antibody was applied for 1 h at 1:50. After incubation, sections 
were washed three times in PBS, with Hoechst nuclear stain 
included in the final wash (1:5000 dilution). In each experiment a 
section was stained without primary antibody to serve as a negative 
control. Fluorescent staining was visualized on a Nikon E400 
microscope and captured using a color digital camera (Digital 
Instrmnents, MI). Some representative sections of each experiment 
were stained instead with hematoxylin and eosin by standard 
methods. 
Corneal Surgeries 
Adult mice (6-8 weeks of age) were anesthetized by an intra- 
peritoneal injection of 2% Avertin (0.017 mt/g body weight). 
Residual eye reflexes were blocked by topical application of 0.5% 
proparacaine to the corneal surface (Alcon, TX)I A circular demar- 
FIG. 1. Localization of Pax~6 in embryonic and adult eyes. hmnunohistochemical detection of Pax-6 protein in El3 (A and B) and adult 
(C-E) wild-type mouse yes. (A) Sagittal E13 section stained for Pax-6 in the presumptive retina, conjunctiva ( rrow), lens epithelium, and 
corneal epithelimn (arrowhead), to be compared with Fig. 2B. (B) Identical section as in {A) counterstained with Hoechst nuclear dye to 
visualize the locations of cell nuclei. (C} Pax~6 staining of adult iris and tens epithelimn (arrowheads), to be compared with Figs. 2C and 
2D. (D) Constitutive Pax-6 staining of adult corneal epithelial cells in cross section. (E) Staining of ganglion ceils (arrowhead) and inner 
nuclear layer retinal cells for Pax-6, to be compared with Figs. 2E and 2F. All images were at 20× original magnification except (A 1 and (B1, 
which were at 10×. 
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cation was created in the central portion of one cornea of each 
mouse by excimer laser keratectomy toa depth of 40 b~m, removing 
the epithelium, basement membrane, and anterior stroma to a 
diameter of 1.5 mm. This is similar to the photorefractive k ratec- 
tomy procedure used in humans to correct refractive rror. Antibi~ 
otic ointment was applied to the eyes after surgery. Mice were 
sacrificed 18 h after surgery at a time when the migrating epithelial 
sheet had almost resurfaced the corneal defect. Reepithelializing 
and control eyes were removed and processed for/3-gal staining or 
immunohistochemistry, as described above. A modified procedure 
was performed on adult New Zealand White rabbits (Charles River 
Laboratories, Wilmington, MA) with the aim of obtaining tissue to 
prepare tysates for EMSA or Western blotting. Rabbits were anes- 
thetized with xylazine and ketamine. Residual reflexes were 
blocked by topical application f 0.5% proparacaine. In this case 
the wound was created by gently pressing an 8-mm trephine on the 
surface of the cornea followed by gentle scraping with a scalpel 
within the circumscribed area. Animals were sacrificed 20 h after 
surgery, and epithelial tissue was immediately collected from the 
area of the wound, or from uninjured corneas, by gentle scraping 
with a scalpel as described (Mohan et al., 1998). 
Electrophoretic Mobility Shift Assay 
Nuclear extracts from cells or corneal epithelial tissues were 
prepared as described (Mohan et aI., 1998), essentially followed the 
procedure of Dignam et al. (1983). Protein concentration was 
measured by Bio-Rad dye binding assay (Bio~Rad, Hercules, CA). 
Aliquots of equal protein were frozen at -70°C and thawed just 
prior to use. The sequences of double-stranded oligonucleotides 
used for EMSA are delineated in Table 1. Probes containing the 
canonical DNA binding sites for transcription factors AP-1, Spl, 
and AP~2 were purchased from Promega Co. (Madison, WI). PDcon 
encodes the optimized Pax-6 paired domain binding site as de- 
scribed (Epstein et al., 1994a). The double-stranded oligo probes 
derived from the gelB promoter were synthesized by the Tufts 
University oligonucteotide facility. 
For each EMSA 0.03 pmol radiolabeled DNA was incubated for 
20 rain at room temperature with equal amounts of ~uclear 
extracts (5-10 ~g or 1-2 bd) from tissues or cell cultures in a 
high-salt DNA binding buffer containing polyIdI-dC ) (Promega), 
according to established protocol. The protein-DNA complexes 
were resolved by electrophoresis ona 4% nondenaturing polyacryL 
mnide gd, dried, and exposed to X~ray film for autoradiography In 
competition experiments, 50 × molar excess of unlabeled probe was 
incubated with nuclear lysates for 10 min before addition of labeled 
oligos. For supershift EMSA, protein-DNA complexes were incu- 
bated with antibodies for an additional 40 rain at room tempera- 
ture. Polyclonal Spl and AP-2 antibodies for supershifts were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Two 
Pax-6 antibodies were used in this study. The Pax-6A (Covance Co., 
Richmond~ CA) and Pax-6B antibodies were both raised to the 
C-terminal domain of mouse Pax-6 as respectively described (Davis 
and Reed, 1996; Xu et al., 1999). Both antibodies recognize similar 
epitopes; however, Pax6A supershifted Pax-Gcontaining com- 
plexes, while Pax6B removed them. Pax-6 paired domain/GST 
fusions (PD/GST and GST control) have been previously described 
(Epstein et ai., 1994a). Recombinant protein was purified on 
glutathione-Sepharose 4B colmnns as recommended by the manu- 
facturer (Pharmacia Biotech, Piscataway, NJ). 
Western Blotting and Densitometry 
Nuclear lysates from normal or resurfacing corneal epithelium 
were prepared as for EMSA. Equal amounts of protein (5 ~gl were 
separated by 11% SDS-PAGE and transferred to Immobilon P 
membrane (Millipore, Bedford, MA). Blots were probed with Pax-6 
antibody at a 1:500 dilution followed by an HRP-conjugated sec- 
ondary and ECL detection reagents as recommended by the manu- 
facturer (Amersham, Arlington Heights, IL). After fihn exposure, 
blots were stained with 0.1% amido black to confirm the equal 
loading of total proteins between lanes. Densitometry was per- 
formed using an Eagle Eye image analyzer (Stratagene}, and values 
were cNculated for duplicate wound and control anes by compari- 
son to a standard curve. 
Cell Culture and Transient Transfection A alysis 
The rabbit corneal epithelial-derived cell line SIRC was cultured 
as recommended by the supplier (American Type Culture Collec- 
tion, Rockville, MD). Cells were plated for transfection as de- 
scribed (Fini et al., 1994). GelB promoter-reporter DNA constructs 
used in tbis study were derived from the rabbit gelB gene (Fini et 
al., 1994). The development of Pr22, Pr34, Pr35, and Pr42 was 
previously described (Mohan et al., 1998). Development of Pr15 
was also previously described (Fini et aI., 1994). A new construct, 
Pr23, was created by insertion of a 2.4-kb fragment of genomic 
DNA into the EcoRI  site of Pr22; this extends the gelB 5' flanking 
DNA an additional 2,4 kb upstream. The reporter gene used in each 
construct is the gene for either/3-galactosidase (/3-gal) or chtoram~ 
phenicol acetyttransferase (CAT). A fulldength Pax-6 expression 
plasmid was previously described {Epstein et al., 1994a). Plasmid 
DNAs were purified using the Qiagen plasnrid DNA purification 
kit (Qiagen, Santa Clarita, CA). In a standard transfection, 1 /xg of 
a gelB construct was cotransfected with either 0.4/~g of the Pax-6 
expression plasmid or control DNA. A second reporter plasmid (0.8 
b~g) driven by a strong and ubiquitously active promoter was 
included to control for any differences in transfection efficiencies. 
The control vector used was either the CMV-/3-Galactosidase 
Control Vector (Stratagene, La Jolla, CA) or the pCAT control 
FIG, 2. Localization of gelB promoter activity in the eyes of transgenic mouse line3445. Gelatinase Bpromoter activity in mouse line 3445 
detected by histochemical localization of/3-hal expression in E13 (A and B) and adult (C-F) mice. (Top) The Pr22 transgene. (A) Strong/3-hal 
expression is observed in El3 eyes and nasal cavities (arrowheads). (B) Sagittal section through an E13 eye showing/3-hal staining of retinal 
precursor ceils in the inner layer of the optic cup (arrow) and epithelium of the cleft between the corneal, limbus and eyelid (future 
conjunctiva) (arrowhead). (C) Hematoxylin- and eosin~stained section showing adult iris and tens, followed by an equivalent section 
showing the iris and lens epithelium stained for ]3-gal (D) (arrowheads). Note the arrow in (D} indicating artifactual dark marks in the lens 
fibers. (E) Hematoxylin- and eosin-stained section showing adult retina, with the arrowhead indicating the ganglion cell layer, followed by 
an equivalent section staining in the ganglion cells for ]3-gal (F). All images were at 20× original magnification except (B), which was at 10×. 
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plasmid [Promega), thechoice being the alternative to whichever 
reporter was being utilized in the gelB construct under analysis. 
Total DNA transfected was equalized in all cases with empty 
expression vector. DNA was introduced into cells using Lipo- 
fectamine reagent fotlowmg the procedure recommended by the 
manufacturer tLife Technologies, Gaithersburg, MDJ All transfec~ 
tions were done at least three separate times in triplicate. Cells 
were collected 24 h after treatnrent and cell lysates were assaye d for 
]3*galactosidase ctivity (Holcomb and Silhavy, 1972). An eqniva~ 
lent volume of each lysate was then assayed for CAT activity using 
[HC]chloramphenicol as a substrate and quantified by scintillation 
counter (Gorman et al., 1982; Seed and Sheen, 1988). Results were 
then normalized to/3-galactosidase expression. 
RESULTS 
Pax-6 Expression Patterns Overlap GelB Promoter 
Activity in Embryonic and Adult Mouse Eyes 
Pax-6 expression patterns were observed in El3 and adult 
mouse eyes by imm.unofluorescence localization (F g. 1). 
The Pax-6 expression profile essentially matched that de- 
scribed in detail for chick and mouse eyes by Koroma et al. 
(1997). Briefly, nuclear staining was present in El3 corneal 
epithelium, future conjunctiva, and retina, as well as in 
adult corneal epithelium, conjunctiva, lens epithelium, and 
ganglion and inner maclear etinal ayers (Fig. 1). Localiza- 
tion of gelB transcriptional promoter activity in embryonic 
and adult eyes was investigated by assaying expression of 
the/3-gal reporter gene driven by the gelB promoter in line 
3445 transgenic mice (Fig. 2). We previously reported strong 
histochemical staining for ]3-gal in the brain of these mice 
at E l l  (Mohan et al., 1998). At E13, staining in the brain 
was reduced; however, staining in the eye and nasal cavities 
was intense {Fig. 2A). At this and all other times assayed, 
littermates that did not carry the transgene were negative 
for t3-gal staining (Mohan et aI., 1998). 
To compare the activity pattern of the gelB promoter and 
the expression of Pax-6 in the different issues of the eye, 
we examined sagittal sections through E13 and adult eyes of 
line 3445 and control mice. Histochemical staining for 
]3-gal at El3 was localized in the retinal precursor cells 
which make up the inner layer of the optic cup and to a
specific area of the future conjunctival epithelium within 
the cleft between eyelid and cornea (Fig. 2B). Additionally, 
in some sections, weak staining was observed in lens 
epithelial cells (not shown). This pattern overlaps with the 
localization of Pax-6 in presumptive conjunctiva, retina, 
and lens epithelium; however, the gelB promoter was not 
active in the corneal epithelium, a prominent Pax-6 stain- 
ing site (Figs. 1A and 1B). 
In adult eyes, staining for/3-gal was localized to the lens 
epithelimn, the stromal ayer of the iris, the mesenchy- 
mally derived tissues of the ciliary body (Fig. 2C), and the 
ganglion cell ayer of the retina (Fig. 2E). The expression 
pattern for Pax-6 overlaps with the gelB activity pattern in 
the lens epithelium, iris, and ciliary body (Fig. 1C) and 
ganglion cell layer of the adult retina (Fig. 1E), but Pax-6 
was also expressed in the cells of the inner nuclear layer 
(Fig. 1E). Pax-6 continued to be expressed in the corneal 
epithelium of the adult eye (Fig. 1D); however, as in 
embryos, the gelB promoter continued to be inactive at this 
location (not shown). 
These data dernonstrate considerable overlap between 
the tissue localization patterns of gelB promoter activity 
and Pax-6 expression i  the eye, yet also reveal significant 
differences. 
Colocalization of GelB Promoter Activity and 
Pax-6 Expression in Reepithelializing Corneas 
While gelB is not normally expressed in the cornea of 
the developing or adult eye, expression is induced in 
adult corneal epithelium migrating to repair a wound 
(Fini et al., 1996). This induction provides auseful model 
for studying gelB transcriptional regulation, as the co> 
neal epitheliuln is a tissue with clearly delineated mar- 
gins that is easy to isolate. We investigated the localiza- 
tion of gelB promoter activity in repairing corneal 
epithelium of line 3445 transgenic mice (Mohan et al., 
1998). As predicted by the expression pattern of the 
endogenous gelg gene, uninjured corneas were negative 
for/3-gal activity; however, activity was detectable in the 
corneal epithelium migrating to heal a wound (Figs. 3A 
and 3B). Activity was localized to  the basal cell layer, 
similar to the reported pattern of endogenous gelB expres- 
sion (Matsubara et al., 1991; Fini et aI., 1996). As de- 
scribed above, Pax-6 is constitutively expressed through- 
out the cells of the corneal epithelium (Fig. 1D). Sections 
from reepithelializing corneas stained for Pax-6 showed 
no major changes in localization; however, an increase in 
staining intensity was observed in ceils at the migrating 
wound edge (Fig. 3C). These findings demonstrate overlap 
between Pax-6 expression i  corneal epithelium and gelB 
promoter activity induced as part of the repair response 
in the cornea. 
Increase in Pax-6 Protein and DNA Binding 
Activity in Reepithelializing Corneas 
To investigate potential changes in the expression 
levels of Pax-6 in epithelium during repair, a Western 
blot analysis was performed (Fig. 4A). Equal amounts of 
control or wound rabbit epithelial Iysates were loaded 
into duplicate lanes. In both cases the Pax-6 antibody 
bound proteins of 46-48 kDa corresponding to the two 
major Pax-6 isoforms (Fig. 4A, lanes C and W). A control 
lysate from corneal fibroblasts was negative for immuno- 
reactive Pax~6 (Fig. 4A, lane F). Plotting of experimental 
values against a standard curve revealed a threefold 
increase of Pax-6 protein in wound lysates compared to 
lysates from uninjured cells (Fig. 4B). 
To investigate relative DNA binding activity for the 
Pax-6 paired domain in normal and wounded corneal 
epithelium, EMSA was performed on nuclear extracts 
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epithelium compared to extracts from uninjured epithe- 
limn. EMSA using probes for other transcription factors 
known to regulate gelatinase B activity are shown for 
comparison. The increased binding of Pax-6 was greater 
than the increase in NF-KB or AP-1 activities in wound 
lysates, but quite rnodest in comparison with the change 
in Spl DNA binding activity (Fig. 4D). 
These data reveal that both the dosage of Pax-6 and the 
level of Pax-6 DNA binding activity are increased in repair- 
ing corneal epithelium. 
FIG. 3. Colocalization of gelB promoter activity with Pax-6 pro- 
tein in wounded corneas. Cross ections through laser-wounded 
adult mouse corneas showing the edge of epithelial regrowth 
(arrowheads in (A-C)). (A) Hematoxytin- and eosin-stained section 
and equivalent sections in (B) showing ]3-gal promoter activity in 
the migrating wound epithelium of a line 3445 mouse and {C) 
intensified Pax-6 staining at the wound edge. Note that the 
contrast in (C) has been reduced to diminish the constitutive 
background epithelial P~x°6 staining. All images were at 20× 
original magnification~ 
derived from the same lysates used for Western blotting 
described above. The double-stranded oligonucleotide, 
PDcon, presenting an optimized Paxo6 DNA binding site, 
served as probe for this experiment (Table 1). Nuclear 
extracts prepared from uninjured epithelium revealed a 
single major protein:DNA complex which was competed 
with an excess of unlabeled PDcon, but not an unrelated 
oligonucleotide (Fig. 4C). The mobility of the complex 
was supershifted by preincubation with one Pax-6 anti ~ 
body (Pax-6A) and abolished by a second Pax-6 antibody 
(Pax-6B}, demonstrating that it contains Pax-6 (Fig. 4C). 
Antibodies recognizing transcription factors AP-2 or Spl 
did not affect the DNA binding activity of the protein 
complex to the PDcon probe (Fig. 4C). An identical 
complex formed on PDcon when nuclear extracts pre- 
pared from migrating wound epithelium were used for 
EMSA (Fig. 4D). However, the amount of binding to the 
PDcon probe was increased with extracts from wound 
Pax-6 Activates the GelB Promoter in Cultured 
Corneal Epithelial Cells 
To test the hypothesis that increased dosage of Pax-6 
protein stimulates gelB promoter activity in corneal epithe- 
lial cells, we performed cell co-transfection experiments 
with a set of gelB reporter constructs and an expression 
plasmid encoding the 46 kDa form of Pax-6 (Epstein et al., 
1994a I. To provide sufficient material for analysis, experi- 
ments were done using a spontaneously immortalized cell 
line derived from rabbit corneal epithelium (SIRC), which 
constitutively expresses gelB (Fini et aI, 1994). These cells 
were also found to express Pax-6 endogenously, as deter- 
mined by Western blot analysis (Fig. 5, top). Cotransfec- 
tions were initially performed with a construct driven by 
approximately 3 kb of gelB promoter DNA (Pr23, Fig. 5), and 
the Pax-6 expression plasmid at a range of doses. We found 
that the maximal Pax-6 induction of the reporter genes 
occurred with 0.4 ~g of Pax*6 expression vector per trans- 
fection. Increased osages reduced the induction back to 
basal levels; however, they did not repress reporter expres- 
sion up to 2.0 ~g (not shown). This narrow window of 
activity is consistent with the importance of Pax-6 dosage 
to proper developmental ctivity (Schedl et al., 1996). 
Subsequent experiments were performed with the in&m- 
tive 0.4-/xg plasmid dose. The results are summarized in 
Fig. 5. 
While cotransfection with Pax-6 increased expression of 
Pr23 by about threefold, Pax-6 did not alter activity of Pr22, 
a construct driven by a considerably shortened fragment of 
promoter DNA located between -522 and +19 of the 
transcription start site of the gelB gene. This suggests that 
there is a positive response lement for Pax-6 in the gelB 
promoter located 5' of base -522. However, cotransfection 
with Pax-6 also induced expression of Pr42, a modified 
version of Pr22 generated by internal deletion between 
bases -g12 and -92. This suggested that the promoter 
DNA in Pr22 also contains a positive Pax-6-response ele- 
ment, but the positive response is cancelled out by a 
negative response lement located between bases -312 and 
-92. In support of this hypothesis, expression of Prl5, 
which contains promoter DNA up to the proximal end of 
the deletion in Pr42 (-333 to +19), was repressed by 
cotransfection with Pax-6, and expression of Pr34, which 
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FIG, 4. Induction of Pax4 protein and DNA binding activity in normal and wounded corneas, (A) Western blot probes with Pax-6 antibody 
to nuclear lysates from control (lanes C) and wounded (lanes W) rabbit corneal epithelium, (Lane F) A control ysate from corneal stromal 
cells which do not express Pax~6. (B) Densitometric analysis of the blot in (A) plotted against astandard curve showing a threefold increase 
in Pax-6 wound lysates (w) over controls (c). (C and D) EMSAs showing an increase in Pax-6 DNA binding activity in wounded corneal rabbit 
epithelimn. (C) When a Pax-6 paired domain binding consensus probe [PDcon) was incubated with nuclear lysates from control rabbit 
corneal epithelium, a clear Pax-6 binding band was produced (arrow). One Pax-6 antibody supershifted the band (arrowhead; lane Pax-6A), 
and one rem.oved the band (lane Pax-6B)~ Antibodies for Spl or AP-2 had no effect. (D) Control (lanes C) and wound (lanes W) nuclear lysates 
incubated with Pax-6 paired domain binding consensus probe (PDcon) show an increase in DNA binding in the wound lysates, compared 
with other transcription factors AP-t, NF-KB, AP-2, and Spl binding to their consensus probes. 
contains promoter DNA from base -92  to +19, was not 
significantly affected by cotransfection with Pax-& To- 
gether, these data define a region of posit ive response to 
Pax-6 between bases -522  and -312.  Pr35, a construct 
generated from Pr42 by internal deletion between -438  and 
+19 and addit ion of 5' sequences ( -566 to -522), also 
responded posit ively to cotransfection with Pax-6, consis- 
tent with our conclusions about the location of response 
elements. 
Pax-6 Protein Binds to DNA Elements Located in 
the Positive Response Region of the GelB Promoter 
To identify DNA elements involved in Pax-6 interact ion 
which might be involved in posit ive response, we scanned 
the sequence of the gelB promoter between bases -600  and 
-92  with the aim of identifying candidate regions with 
similar ity to the canonical Pax-6 binding site, as well  as 
regions of overall high cross-species conservation (Fini et 
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FIG. 5. Pax-6 activates the gelB promoter in corneal epithelial cells. Various gelB promoter constructs were t ansiently transfected with 
and without a cotransfected Pax-6 expression vector, into a corneal epithelial cell line(SIRC). The top shows a Western blot with Pax-6 
antibody comparing equal lysates from pmnary corneal epithelial cells (P) and SIRC cells (S). Below are gelB constructs depicted with key 
AP-t, Sp 1, and AP-2 binding sites beside each corresponding co struct name and Pax-6-induced response on the right. Fold getB induction 
was calculated by dividing multiple Pax-6-transfected responses with controls (set to1). 
al., 1994). Five oligonucleotide probes were prepared from 
these regions (Table 1) and tested for their capacity o bind 
Pax-6 by EMSA, using cell lysates from SIRC cells trans- 
fected with the Pax-6 expression plasmid. Cells were trans- 
fected at the same positive dose used for the promoter 
activity analysis described above, since these cells were the 
ones in which the gelB promoter was induced. A represen- 
tative experiment using probe RM72/73 is shown in Fig. 
6A. Several protein-DNA complexes formed on this probe, 
all of which were competed with 50-fold excess of cold 
probe. However, a 50-fold excess of an unrelated oligonu- 
cleotide (AP-lcon) did not compete away any of the com- 
plexes, indicating specificity for DNA sequences in RM72/ 
73. In contrast, an excess of unlabeled PDcon efficiently and 
specifically competed the slowest mobility complex {ar- 
row). Pretreatment with Pax-6 antibody also completely 
eliminated this complex {Pax-6B). These data indicate that 
Pax-6 protein is part of the slowest protein-DNA complex 
that forms with RM72/73. Similar results were obtained 
when lysates from untransfected cells were used (not 
shown). Similar results were also obtained with RM80/81; 
in contrast, the other three probes did not bind Pax-6 (data 
not shown). These data identify two binding sites for Pax-6 
within the positive response region of the gelB promoter. 
Pax-6 could bind directly to its interaction sites in the 
gelB promoter; however, it could also bind indirectly via 
another protein or proteins. To distinguish between these 
two possibilities, we performed EMSA using a purified 
Pax-6 paired domain, expressed as a GST fusion protein. 
Results are shown in Fig. 6B. Incubation of the PDcon probe 
with the fusion protein resulted in formation of a DNA- 
protein complex doublet. In contrast, GST alone did not 
bind the PDcon probe. This shows that fusion of the paired 
domain to the GST protein confers appropriate binding 
specificity for PDcon. GST alone did not bind to RM72/73; 
however, the fusion protein did bind to RM72/73. This 
experiment shows direct binding of the Pax-6 paired do- 
main to RM72/73, without the aid of other proteins. 
DISCUSSION 
Evidence has been accumulating to support the idea that 
MMPs act as true morphogenetic regulators (Werb and 
Chin, 1998). For MMPs to function in this way, their 
activity must be precisely controlled; regulation occurs 
primarily at the level of transcription (Fini et aI., 1998). A 
large body of work has defined transcription factors control- 
ling MMP gene expression in response to stress-related 
stimuli in cultured cells (Fini et al., 1998); however, factors 
controlling MMP gene expression in response to morpho- 
genetic signals are essentially unknown. In this study, we 
provide the first such example, to our knowledge, implicat- 
ing the product of a gene which resides at the very top of the 
genetic hierarchy for eye development: he gene encoding 
the homeo- and paired domain-containing transcription 
factor Pax-6. We correlated gelB promoter activity in vivo in 
embryonic and adult eyes with the pattern of Pax-6 expres- 
sion. We further documented upregulation of Pax-6 expres- 
sion and activity in repairing corneal wounds, in correlation 
with induction of gelB promoter activity. Then, using cell 
transfection studies, we directly demonstrated that Pax-6 
stimulates gelB promoter activity and defined three regions 
within the promoter for Pax-6 response. EMSA with cell 
lysates allowed us to identify two specific DNA elements 
that bind immunoreactive Pax-6, located within a positive 
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FIG, 6. Pax-6 binds specifically to sequences located in the 
positive response region of thegelB promoter. (A) EMSA showing 
the RM72/73 gelB promoter probe binding proteins from nuclear 
lysates made from Pax-6-transfected SIRC cells. Arrow points to a
band that is specifically corapeted by a Pax~6 paired domain 
binding consensus sequence (PDcon) and a Pax-6 antibody (Pax-6B). 
(B1 EMSA showing specific binding of a Pax-6 paired domain GST 
fusion protein (PD/GST) to both a paired omain binding consen- 
sus probe tPDcon) and the RM72/73 probe from the gelB promoter 
(arrow). 
Pax-6 response region of the gelB promoter. Finally, EMSA 
with a purified Pax-6 PD allowed us to show that Pax-6 has 
the potential to bind directly with the gelB promoter DNA 
within this region. These data suggest a mechanism by 
which gelB expression may be directed in an eye-specific 
manner. 
Correlation of GelB Promoter Activity in Vivo 
with Pax-6 Expression and Activity 
Transgenic mouse line 3445, which, harbors a /3-gal re- 
porter gene construct driven by -522 to +19 of the gelB 
promoter (Mohan et aL, 1998), was used to map gelB 
promoter activity in eyes. We have previously demon- 
strated that gelB promoter activity reflects the endogenous 
gelB gene expression pattern in this line of mice (Mohan et 
al., 1998). In this study we found considerable overlap 
between the pattern of gelB promoter activity and the 
pattern of Pax% expression. On the other hand, there were 
several prominent sites of Pax-6 expression -where the 
promoter was not active, in particular, the corneal epithe- 
lium. 
Genetic studies have revealed that Pax-6 gene dosage 
profoundly influences phenotype of embryos and adult 
(Read, 1995; Schedl et al., 1996). This appears to reflect an 
exquisite sensitivity of the cells in a tissue to the level of 
Pax-6 activity. Expression and activity of many transcrip- 
tion factors increase in the epithelium migrating to resur- 
face a corneal wound (Mohan et al., 1998), and the conse- 
quences of this might be similar in some cases to an 
increase in genetic dosage. Since the corneal epithelium of 
the eye is a major expression site for Pax-6 in both embryos 
and adults, we investigated changes in Pax-6 expression and 
activity during corneal reepithelialization. We found that 
the levels of both Pax-6 protein and DNA bindi.ng activity 
for the Pax°6 PD were increased in extracts from migrating 
repair epithelium compared to uninjured epithelium. Inter- 
estingly, this change correlated with induction of gelB 
promoter activity in the repairing corneal epithelium of line 
3445 transgenic mice. Considering the results of our trans- 
fection analysis, these findings suggest hat increased os- 
age of Pax-6 activity could contribute to induction of gelB 
expression during reepithelialization. 
In the cell transfection analysis as performed in this 
study, positive and negative response regions in the -52.2 to 
+19 portion of the gelB promoter precisely balanced each 
other's activity, resulting in a net zero effect. It is this 
promoter that drives reporter gene expression in the DNA 
construct harbored by our line 3445 mice (Mohan et al,, 
1998). This does not argue against a role for Pax4 in 
controlling gelB promoter activity in vivo; we previously 
showed that cell culture cannot perfectly reproduce the 
conditions associated with gelB promoter regulation in 
wounds (Mohan et al., 1998). Other transcription factors, 
such as AP-2 and Sp 1 are also induced in the healing corneal 
epithelium and have been shown to affect gelB promoter 
activity (Sato and Seiki, 1993; Fini et a]., 1994). It is 
interesting to note that the two potential Pax-6 binding 
sites identified here are situated next to either an AP-2 or an 
Spl site. Ultimately, the final promoter esponse to Pax-6 
would depend on the DNA context of each of the Pax-6- 
response elements; i.e., the capacity to bind interacting 
protein factors and the availability of these factors under 
different in vivo conditions. 
Implications of GelB as a Pax-6 Target Gene 
In its role as a key regulator of eye development, Pax-6 
must ultimately influence the activity of a large number of 
downstream genes which contribute to morphogenesis of
the eye. Indeed, it is well known that Pax-6 directly 
controls expression of other regulatory genes at the top of 
the developmental hierarchy, including DachshunG sine 
oculis, and eyes absent (Fini et aL, 1997). A second class of 
target genes for Pax-6 lies downstream in the hierarchical 
cascade and these genes function in cell differentiation. 
Those identified to date are the crystallins of the mamma- 
Iian lens (Richardson et al., 1995; Cvekl et al., 1995); neural 
cell adhesion molecule L1 (Chalepakis et al., 1994) and 
rhodopsin (Sheng et at., 1997) of the mammalian and 
Drosophila retinas, respectively; and kerat in 13 of the 
cornea (Liu et al., 1999). The function of MMPs as morpho- 
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genetic regulators places gelB in the first class of Pax-6 
target genes. In addition, gelB has some features which 
make it unique as a Pax-6 target gene. Perhaps the most 
important of these is that, although it is expressed in eye 
tissues according to a specific developmental nd adult 
pattern, gelB is not an eye-specific protein. In addition, 
expression of gelB can be induced in virtually any tissue in 
response to stress-related stimuli (Fini eta] . ,  1998). This 
suggests the interesting possibility that Pax-6 functions to 
modulate gelB gene expression so that it will be expressed 
in an eye-appropriate manner. 
GelB is a 92-kDa MMP with proteolytic reactivity against 
extracellular matrix components of basement membranes. 
Based on its embryonic expression pattern, it has been 
postulated to be involved in implantation of the embryo 
into the uterus, as well as bone, brain, and eye develop- 
ment. In support of these ideas, it was recently shown that 
delayed conversion of hypertrophic cartilage to bone occurs 
in developing long bones of mice made genetically deficient 
for gelB. This defect, which is eventually compensated by 
an unknown secondary mechanism, appears to occur as a 
result of impaired vascular invasion of the cartilagenous 
zone (Vu et aI., 1998). Interestingly, the developmental 
localization of gelB expression in the brain and the eye is 
also consistent with a possible role in vascularization 
(Canete-Soler et al., 1995b)~ Unfortunately, gene targeting 
has not been useful in elucidating the function of gelB in 
these organs, which appear to develop normally in gelB- 
deficient mice. 
In adult animals, gelB is synthesized by inflammatory 
cells and gelB-deficient mice have impaired neutrophil 
function (Liu et M., 1998). GelB expression is also induced 
in many adult tissues under conditions of stress in a pattern 
which suggests a role in epithelial repair and angiogenesis 
(Fini et a I., 1998). Overexpression or inappropriate expres- 
sion of gelB has been connected with failure to heal (Mat- 
subara et M., 1991; Fini et aI., 1996,1998) as well as tumor 
invasion and metastasis (Vu and Werb, 1998). 
Given the known functions, what role might gelB play, if 
any, in the phenotypes associated with Pax-6 mutations? 
Homozygosity for a mutant Pax-6 gene results in lethality 
due to severe brain and nasal defects. However, these Pax-6 
mutations are semidominant, resulting in phenotypes of 
haploinsufficiency in heterozygotes. Thus, mice heterozy- 
gously deficient for Pax-6 have small eyes (Hill et aI., 1991). 
In humans, a heterozygous Pax-6 phenotype, aniridia, is 
characterized by various ocular malformations, including 
the lens, iris, cornea, and retina, resulting in cataracts and 
glaucoma (Ton et al., 1991; Glaser et al., 1992 ). Peter's 
anomaly is another human Pax-6-deficient phenotype re- 
sulting in central corneal opacification and angiogenesis, as 
well as adhesion between the lens and the cornea (Hansen 
et al., 1994). Mice overexpressing Pax-6 also have a mi- 
crophthahnia phenotype with reduction in corneal size, iris 
abnomaalities, a disorganized ciliary body, and lens defects 
(Schedl et aL, 1996). Cell lines overexpressing Pax-6 become 
oncogenically transformed (Maulbecker and Gruss, 1993). 
These phenotypes overlap some of the phenotypes associ- 
ated with gelB deficiency or its excessive or inappropriate 
expression. Studies to investigate the connection between 
Pax-6-deficient phenotypes and altered gelB expression are 
under way in our lab. 
While recent work has provided insight into the role of 
Pax-6 in embryonic development, essentially nothing is 
known about its role in adult organs. Our demonstration 
that Pax-6 activity is induced with the repair response in 
cornea is novel, to our knowledge. This finding suggests 
that Pax-6 might exert control over stress-related remodel- 
ing in the eye. Pax-6 has two major splice variants--46- and 
48-kDa forms, each with unique DNA binding properties 
(Epstein et al., 1994b). In the present study we have focused 
on the major 46-kDa variant and its effect on the gelB 
promoter; however, the intriguing possibility exists that a 
change in the relative expression levels of the two forms 
may have a physiological significance. We were unable to 
clearly distinguish the forms in our Western blots presented 
here, but our experience with them suggests that the 
cannonical form of Pax-6 is induced in the wounds, while 
the alternate splice is repressed. Studies are under way to 
investigate this possibility. These and other experiments 
might be undertaken by using viral vectors to alter Pax-6 
activity and dosage in the adult eye. The cornea offers a 
tissue with unique assessibility for such an approach. 
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